Results 31 to 40 of about 9,624 (181)
Expression of the target LOX in ccRCC tissue.
, 2016 Expression of LOX in malignant (ccRCC) and non-malignant (N) renal tissue of 27 ccRCC patients was measured by RT-qPCR. A) and B) show expression differences between paired normal and ccRCC samples. In C) ccRCC tumors are split into non-metastatic (ccRCC-
Ergin Kilic (157051) +5 more
core +1 more source
, 2019 Distribution of GRP78 expression in ccRCC tumor tissue (N = 114) among different categories of ccRCC aggressiveness.
Sharon Juliet Del Vecchio (6239654) +8 more
core +1 more source
Scientific Reports, 2022 The molecular heterogeneity of primary clear cell renal cell carcinoma (ccRCC) has been reported. However, the classifications of Von Hippel–Lindau (VHL) mutant ccRCC are unclear.
Haiwei Wang +3 more
doaj +1 more source
Expression of miR-141-3p and miR-145-5p in ccRCC tissue.
, 2016 Expression of miR-141-3p and miR-145-5p in malignant (ccRCC) and non-malignant (N) renal tissue of 27 ccRCC patients was measured by RT-qPCR. A) and B) show expression differences between paired normal and ccRCC samples. In C) ccRCC tumors are split into
Ergin Kilic (157051) +5 more
core +1 more source
Univariate analysis of overall survival in 526 ccRCC patients.
, 2022 Univariate analysis of overall survival in 526 ccRCC patients.
Tie Chong (655561) +8 more
core +1 more source
Molecular Oncology, EarlyView.LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David +12 more
wiley +1 more source
LOX protein expression pattern in ccRCC.
, 2016 LOX protein expression pattern in ccRCC.
Ergin Kilic (157051) +5 more
core +1 more source
High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
Pharmacogenomics and Personalized Medicine, 2023 Xuegang Wang,1,* Weiquan Li,2,* Ning Lou,3,* Weiwei Han,3 Bo Hai,2 Wen Xiao,2 Xiaoping Zhang2 1Department of Urology, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, People’s Republic of China ...
Wang X +6 more
doaj
MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma
Molecular Metabolism, 2020 Objective: The most common kidney cancer, clear cell renal cell carcinoma (ccRCC), is closely associated with obesity. The “clear cell” variant of RCC gets its name from the large lipid droplets that accumulate in the tumor cells.
Chase K.A. Neumann +10 more
doaj +1 more source
Advanced Science, EarlyView.PTBP1‐mediated alternative splicing drives a pathogenic switch to the DNAJB6b isoform in everolimus‐resistant clear cell renal cell carcinoma. This splicing event programs a positive feedback loop including EIF4B/PKIB/AKT/mTOR, promoting aggressive therapy resistance.
Xiu‐wu Pan +18 more
wiley +1 more source